This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

HAC1

iBio, Inc.

Drug Names(s): iBioLaunch H1N1 Vaccine

Description: HAC1 is a recombinant fusion protein vaccine derived from influenza A/Califonia/04/09 (H1N1) using a proprietary technology for the production of biologics employing transient gene expression in unmodified green plants.


HAC1 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug